Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques

Sophie Geoffron; Guillaume Legendre; Emile Daraï; Émile Daraï; Nathalie Chabbert-Buffet; Nathalie Chabbert‐Buffet

doi:10.1016/j.lpm.2017.10.005

Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques

Sophie Geoffron, Guillaume Legendre, Emile Daraï, Émile Daraï, Nathalie Chabbert-Buffet, Nathalie Chabbert‐Buffet

Presse medicale (Paris, France : 1983) · 2017 · vol. 46(12) , pp. 1199–1211 · doi:10.1016/j.lpm.2017.10.005 · PMID:29133081 · W2767669816

review OA: closed CC0 ⤵ 5 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reviews hormonal treatments for endometriosis, focusing on managing pain and lesion progression while exploring future therapeutic options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715mesh:D017699

MeSH descriptors

Endometriosis Disease Progression Drug Combinations Endometriosis Endometriosis Ethinyl Estradiol Ethinyl Estradiol Female Forecasting Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Norpregnenes Norpregnenes Pain Management Pelvic Pain Pelvic Pain Pelvic Pain Pelvis Progestins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (5)

SciLite annotations

chemicals 4

progestin hormone progestin levonorgestrel

organisms 1

human

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-13T22:20:07.505861+00:00
scilite: last seen: 2026-05-18T04:25:29.313245+00:00
unpaywall: last seen: 2026-06-04T02:00:05.705006+00:00

License: CC0 · commercial use OK

[1] Abdominal wall endometriosis following cesarean section: a study of the growth rate of parietal endometriosis implants via openalex

[2] A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. via openalex

[3] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[4] Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis via openalex

[5] Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex

[6] A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg via openalex

[7] Anti-angiogenic treatment strategies for the therapy of endometriosis via openalex

[8] Anti-TNF-α treatment for pelvic pain associated with endometriosis via openalex

[9] A pilot study on the off-label use of valproic acid to treat adenomyosis via openalex

[10] A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis via openalex

[11] Aromatase and endometriosis: estrogens play a role via openalex

[12] Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis via openalex

[13] Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex

[14] Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex

[15] Clinical characteristics of catamenial and non‐catamenial thoracic endometriosis‐related pneumothorax via openalex

[16] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis via openalex

[17] Comparison of ovarian cyst formation in women using the levonorgestrel‐releasing intrauterine system vs. hysterectomy via openalex

[18] Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex

[19] Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex

[20] Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex

[21] Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study via openalex

[22] Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex

[23] Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis via openalex

[24] Dienogest in the treatment of endometriosis via openalex

[25] Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex

[26] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[27] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex

[28] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[29] Effective post-laparoscopic treatment of endometriosis with dydrogesterone via openalex

[30] Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue via openalex

[31] Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats* via openalex

[32] Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis via openalex

[33] Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis via openalex

[34] Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex

[35] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density via openalex

[36] Endometriosis via openalex

[37] Endometriosis via openalex

[38] Endometriosis: Diagnosis and Management via openalex

[39] Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial via openalex

[40] Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex

[41] Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex

[42] Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex

[43] Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis via openalex

[44] Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report via openalex

[45] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis via openalex

[46] Hormonal therapy after the operation for catamenial pneumothorax – is it always necessary? via openalex

[47] Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells via openalex

[48] Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells<sup>1</sup> via openalex

[49] Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery via openalex

[50] Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial via openalex

[51] Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. via openalex

[52] Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis via openalex

[53] Letrozole and norethisterone acetate in colorectal endometriosis via openalex

[54] Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex

[55] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[56] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[57] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[58] Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex

[59] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[60] MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis via openalex

[61] Multidisciplinary Treatment for Thoracic and Abdominopelvic Endometriosis via openalex

[62] Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group. via openalex

[63] Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study via openalex

[64] One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex

[65] Oral contraceptive pills for endometriosis after conservative surgery: a systematic review and meta-analysis via openalex

[66] Oral contraceptives for pain associated with endometriosis via openalex

[67] Oral contraceptives for pain associated with endometriosis via openalex

[68] Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? via openalex

[69] Oral Estroprogestins after Laparoscopic Surgery to Excise Endometriomas: Continuous or Cyclic Administration? Results of a Multicenter Randomized Study via openalex

[70] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex

[71] Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex

[72] Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex

[73] Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence via openalex

[74] Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex

[75] Postoperative levonorgestrel‐releasing intrauterine system versus oral contraceptives after gonadotropin‐releasing hormone agonist treatment for preventing endometrioma recurrence via openalex

[76] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[77] Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex

[78] Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex

[79] Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis via openalex

[80] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[81] Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex

[82] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex

[83] Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo via openalex

[84] Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex

[85] Return of Chronic Pelvic Pain From Endometriosis After Raloxifene Treatment via openalex

[86] Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex

[87] Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[88] Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life via openalex

[89] The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial via openalex

[90] The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex

[91] The immninent dawn of SPRMs in obstetrics and gynecology via openalex

[92] The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex

[93] The role of the peritoneum in the pathogenesis of endometriosis via openalex

[94] Thoracic Endometriosis Syndrome: A Veritable Pandora’s Box via openalex

[95] Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis via openalex

[96] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex

[97] Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis via openalex

[98] Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device via openalex

[99] Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in Rats via openalex

[100] W2159803441 via openalex